Literature DB >> 4604292

Dantrolene sodium in children with spasticity.

R H Haslam, J R Walcher, P S Lietman, C H Kallman, E D Mellits.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604292

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


× No keyword cloud information.
  7 in total

Review 1.  Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders.

Authors:  Stephen R Deputy; Ann H Tilton
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

Review 2.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

3.  Deep brain stimulation and dantrolene for secondary dystonia in x-linked adrenoleukodystrophy.

Authors:  Clara van Karnebeek; Gabriella Horvath; Tyler Murphy; Jacqueline Purtzki; Kristin Bowden; Sandra Sirrs; Christopher R Honey; Sylvia Stockler
Journal:  JIMD Rep       Date:  2014-04-10

Review 4.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

Review 5.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 6.  Nonoperative management of spasticity in children.

Authors:  Susan Ronan; Joan T Gold
Journal:  Childs Nerv Syst       Date:  2007-07-24       Impact factor: 1.475

7.  The effect of combined transcranial pulsed current stimulation and transcutaneous electrical nerve stimulation on lower limb spasticity in children with spastic cerebral palsy: a randomized and controlled clinical study.

Authors:  Zhenhuan Liu; Shangsheng Dong; Sandra Zhong; Fang Huang; Chuntao Zhang; Yuan Zhou; Haorong Deng
Journal:  BMC Pediatr       Date:  2021-03-24       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.